Glutamate neurotoxicity and diseases of the nervous system

Neuron

Volumn 1, Issue 8, 1988, Pages 623-634

  Choi, Dennis W ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; GLUTAMATE RECEPTOR; GLUTAMIC ACID; GLUTAMIC ACID DERIVATIVE; NEUROTOXIN; NEUROTRANSMITTER RECEPTOR;

ANIMAL; DRUG EFFECT; HUMAN; METABOLISM; NEUROLOGIC DISEASE; PHYSIOLOGY; REVIEW;

ANIMAL; CALCIUM; GLUTAMATES; GLUTAMIC ACID; HUMAN; NERVOUS SYSTEM DISEASES; NEUROTOXINS; RECEPTORS, GLUTAMATE; RECEPTORS, NEUROTRANSMITTER; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0024093449     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/0896-6273(88)90162-6     Document Type: Review

References (150)

1. Low doses of l-monosodium glutamate promote neuronal growth and differentiation in vitro
2. Electrophysiological studies of NMDA receptors
3. Quisqualate- and kainate-activated channels in mouse central neurones in culture
4. Progress review: hypoglycemic brain damage
5. Replication of the neurochemical characteristics of Huntingtons disease by quinolinic acid
6. Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy
7. Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis
8. Neuropathological changes in the rat brain cortex in vitro: effects of kainic acid and of ion substitutions
9. Influence of cortio-striatal afferents on striatal kainic acid neurotoxicity
10. The N-methyl-d-aspartate antagonists CGS 19755 and CPP reduce ischemic brain damage in gerbils
11. Novel 21-amino steroids as potent inhibitors of iron-dependent lipid peroxidation
12. Transient formation of superoxide radicals in polyunsaturated fatty acid induced brain swelling
13. Calcium and ischemic injury.
14. Ionic dependence of glutamate neurotoxicity in cortical cell culture
15. Glutamate neurotoxicity in cortical cell culture
16. Pharmacology of glutamate neurotoxicity in cortical cell culture: attenuation by NMDA antagonists
17. Ketamine and MK-801 as neuroprotective agents in cerebral ischemia/hypoxia
18. NMDA receptors-their role in long-term potentiation
19. Focal cortical seizures cause distant thalamic lesions
20. 2+ induced by excitatory amino acids in CA1 hippocampal neurons
21. Adenosine decreases aspartate and glutamate release from rat hippocampal slices
22. Neuropathology of status epilepticus in humans
23. Lesion of striatal neurones with kainic acid provides a model for Huntington's chorea
24. Excitatory amino acid neurotoxins: selectivity, specificity, and mechanisms of action
25. Multiple-conductance channels activated by excitatory amino acids in cerebellar neurons
26. Noise and single channels activated by excitatory amino acids in rat cerebellar granule neurones
27. Amino acid transmitters in the mammalian central nervous system
28. No evidence for preservation of somatostatin-containing neurons after intrastriatal injections of quinolinic acid
29. Depressant actions of gamma-d-glutamylaminomethyl sulfonate (GAMS) on amino acid-induced and synaptic excitation in the cat spinal cord
30. Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementia
31. The effects of convulsant and anticonvulsant drugs on the release of radiolabeled GABA, glutamate, noradrenaline, serotonin and acetylcholine from rat cortical slices
32. Controlled induction of paired helical filaments of the Alzheimer type in cultured human neurons, by glutamate and aspartate
33. Calcium accumulation and neuronal damage in the rat hippocampus following cerebral ischemia
34. In vitro release and electrophysiological effects in situ of homocysteic acid, an endogenous N-methyl-(d)-aspartic acid agonist, in the mammalian striatum
35. Cellular origin of ischemia-induced glutamate release from brain tissue in vivo and in vitro
36. Mechanism of kainate toxicity to cerebellar neurons in vitro is analogous to reperfusion tissue injury
37. An adenosine analogue, 2-chloroadenosine, protects against long term development of ischaemic cell loss in the rat hippocampus
38. A potential role for excitotoxins in the pathophysiology of spinal cord injury
39. Selective sparing of a class of striatal neurons in Huntingtons disease
40. Sparing of acetylcholinesterase-containing striatal neurons in Huntingtons disease
41. Applications of quantitative measurements for assessing glutamate neurotoxicity
42. Glycine reverses antagonism of N-methyl-d-aspartate (NMDA) by 1-hydroxy-3-aminopyrrolidone-2 (HA-966) but not by d-2-amino-5-phosphonovalerate (D-AP5) on rat cortical slices
43. Systemic administration of MK-801 protects against ischaemiainduced hippocampal neurodegeneration in the gerbil
44. The response of GABAergic and cholinergic neurons to transient cerebral ischemia
45. Neurodegenerative disorders of the western Pacific: the search for mechanisms of pathogenesis
46. Neurotoxicity of excitatory amino acid receptor agonists in rat cerebellar slices: dependence on calcium concentration
47. Dextromethorphan reduces neocortical ischemic neuronal damage in vivo
48. Kynurenate inhibition of cell excitation decreases stroke size and deficits
49. Systemic administration of MK-801 protects against ischemia-induced hippocampal neurodegeneration in the gerbil
50. N-methyl-d-aspartate receptors mediate hypoxic neuronal injury in cortical culture
51. Hypoxic neuronal injury in vitro depends on extracellular glutamine
52. Adenosine reduces cortical neuronal injury induced by oxygen or glucose deprivation in vitro
53. Phencyclidine receptor ligands attenuate cortical neuronal injury following N-methyl-d-aspartate exposure or hypoxia
54. 2+ solutions
55. Auto radiographic characterization of N-methyl-d-aspartate-, quisqualate-, and kainate-sensitive glutamate binding sites
56. Evidence for transient perinatal glutamatergic innervation of globus pallidus
57. Status epilepticus: the reversibility of calcium loading and acute neuronal pathological changes in the rat hippocampus
58. A polymorphic DNA marker genetically linked to Huntington's disease
59. Effect of anoxia on ion distribution in the brain
60. Status epilepticus: frequency, etiology, and neuropathological sequelae
61. Selective alteration of neurotransmitter release by low oxygen in vitro
62. Ketamine and phencyclidine cause a voltage-dependent block of responses to ]l-aspartic acid
63. Quinoxalinediones: potent competitive non-NMDA glutamate receptor antagonists
64. Block of N-methyl-d-as-partate-activated current by the anticonvulsant MK-801: selective binding to open channels
65. Glutamate activates multiple single channel conductances in hippocampal neurons
66. Resistance of hippocampal CA-1 interneurones to 20 min of transient cerebral ischemia in the rat
67. Ischemic CA-1 pyramidal cell loss is prevented by preischemic colchicine destruction of dentate gyrus granule cells
68. Glycine potentiates the NMDA response in cultured mouse brain neurons
69. Action of the neurotoxin kainic acid on high affinity uptake of l-glutamic acid in rat brain slices
70. The role of protein kinase C in the regulation of ion channels and neurotransmitter release
71. Mechanisms involved in irreversible anoxic damage to the in vitro rat hippocampal slice
72. Noncompetitive antagonists of excitatory amino acid receptors
73. Quinolinate neurotoxicity in cortical cell culture
74. l-Homocysteate is a potent neurotoxin on cultured cortical neurons
75. Delayed neuronal death in the gerbil hippocampus following ischemia
76. Requirements for glycine in activation of NMDA-receptors expressed in Xenopus oocytes
77. Glutamate antagonist therapy reduces neurologic deficits produced by focal central nervous system ischemia
78. Cultured striatal neurons containing NADPH-diaphorase or acetylcholinesterase are selectively resistant to injury by NMDA receptor agonists
79. Zinc alters excitatory amino acid neurotoxicity on cortical neurons
80. Neurons containing NADPH-diaphorase are selectively resistant to quinolinate toxicity
81. Coexpression of N-methyl-d-aspartate and phencyclidine receptors in Xenopus oocytes injected with rat brain mRNA
82. Calcium-mediated myopathy at neuromuscular junctions of normal and dystrophic muscle
83. Excitatory amino acids and phencyclidine-like drugs
84. The toxic effect of sodium l-glutamate on the inner layers of the retina
85. Receptors, ion channels and synaptic potentials underlying the integrative actions of excitatory amino acids
86. Chronic infusion of endogenous excitatory amino acids into rat striatum and hippocampus
87. Ketamine prevents glutamate-induced calcium influx and ischemia nerve cell injury
88. Huntington's disease: new approaches to an old problem. The Robert Wartenberg lecture
89. Neurite outgrowth in individual neurons of a neuronal population is differentially regulated by calcium and cyclic AMP
90. The physiology of excitatory amino acids in the vertebrate central nervous system
91. MK-801 protects the neonatal brain from hypoxic-ischemic damage
92. Duplication of biochemical changes of Huntington's chorea by intrastriatal injections of glutamic and kainic acids
93. Kainic acidinduced degeneration of neostriatal neurons: dependency upon cortico-striatal tract
94. 3H-l-glutamate binding sites
95. Morphinans attenuate cortical neuronal injury induced by glucose deprivation in vitro
96. The effects of excitatory amino acids on intracellular calcium in single mouse striatal neurons in vitro
97. Calcium-dependent glutamate cytotoxicity in a neuronal cell line
98. The regulation of cytosolic calcium in rat brain synaptosomes by sodium-dependent calcium efflux
99. Intraventricular kainic acid preferentially destroys hippocampal pyramidal cells
100. Ketamine reduces neurological deficit following 10 minutes of cardiac arrest and resuscitation in canines
101. The activation of inositol phospholipid metabolism as a signal-transducing system for excitatory amino acids in primary cultures of cerebellar granule cells
102. The current excitement in long-term potentiation
103. Inciting excitotoxic cytocide among central neurons
104. Glutamate neurotoxicity and Huntington's chorea
105. Brain lesions in an infant rhesus monkey treated with monosodium glutamate
106. Cytotoxic effects of acidic and sulfur containing amino acids on the infant mouse central nervous system
107. CysteineS-sulfate: brain damaging metabolite in sulfite oxidase deficiency
108. The role of specific ions in glutamate neurotoxicity
109. Lesions to Schaffer collaterals prevent ischemic death of CAl pyramidal cells
110. Protective effect of the glutamate antagonist, MK-801 in focal cerebral ischemia in the cat
111. Zinc selectively blocks the action of N-methyl-d-aspartate on cortical neurons
112. Abnormal glutamate metabolism in amyotrophic lateral sclerosis
113. Abnormal glutamate metabolism in an adult-onset degenerative neurological disorder
114. Dextromethorphan protects against cerebral infarction in a rat model of hypoxia-ischemia
115. Temporal profile of neuronal damage in a model of transient forebrain ischemia
116. Hypoxia preferentially destroys GABAergic neurons in developing rat neocortex explants in culture
117. Reduced amounts of immunoreactive somatostatin in the temporal cortex in senile dementia of Alzheimer type
118. Synaptic activity mediates death of hypoxic neurons
119. Synaptic release of excitatory amino acid neurotransmitter mediates anoxic neuronal death
120. The neurotoxicity of excitatory amino acids is produced by passive chloride influx
121. Glutamate and the pathophysiology of hypoxic-ischemic brain damage
122. Delayed neurotoxicity of excitatory amino acids in vitro
123. Spider toxin (JSTX) blocks glutamate synapse in hippocampal pyramidal neurons
124. Extracellular overflow of neuroactive amino acids during severe insulin-induced hypoglycemia: in vivo dialysis of the rat hippocampus
125. Transport and metabolism of glutamate and GABA in neurons and glial cells
126. Quinolinic acid: an endogenous metabolite that produces axonsparing lesions in rat brain
127. Historical overview: calcium, ischemia and death of brain cells
128. Excitatory amino acids activate calpain I and induce structural protein breakdown in vivo
129. Calcium overload in selectively vulnerable neurons of the hippocampus during and after ischemia: an electron microscopy study in the rat
130. Blockade of N-methyl-d-aspartate receptors may protect against ischemic damage in the brain
131. Excitotoxic mechanisms in hypoglycaemic hippocampal injury
132. Inhibition of excitatory neurotransmission with kynurenate reduces brain edema in neonatal anoxia
133. Glutamate stimulates inositol phosphate formation in striatal neurones
134. “Epileptic” brain damage in rats induced by sustained electrical stimulation of the perforant path. I. Acute electrophysiological and light microscopic studies
135. Decreased hippocampal inhibition and a selective loss of interneurons in experimental epilepsy
136. “Epileptic” brain damage is replicated qualitatively in the rat hippocampus by central injection of glutamate or aspartate but not by GABA or acetylcholine
137. Lathyrism: evidence for role of the neuroexcitatory amino acid BOAA
138. Guam amyotrophic lateral sclerosis-Parkinsonism-dementia linked to a plant excitant neurotoxina
139. Delayed treatment with dextromethorphan and dextrorphan reduces cerebral damage after transient focal ischemia
140. Quinolinic acid and other kynurenines in the central nervous system
141. A new type of glutamate receptor linked to inositol phospholipid metabolism
142. Ganglioside inhibition of glutamate-mediated protein kinase C translocation in primary cultures of cerebellar neurons
143. Feline generalized penicillin epilepsy: changes of glutamic acid and taurine parallel the progressive increase in excitability of the cortex
144. Agonists and antagonists for excitatory amino acid receptors
145. Beta-N-methylamino-l-alanine (BMAA) neurotoxicity on murine cortical neurons
146. Ketamine protects cultured neocortical neurons from hypoxic injury
147. 2+ antagonize NMDA and GABA responses of hippocampal neurons
148. Hypoglycemia-induced neuronal damage prevented by an N-methyl-d-aspartate antagonist
149. NMDA receptor losses in putamen from patients with Huntingtons disease
150. Extracellular calcium ionic activity in experimental spinal contusion